Compound 421
Identifiers
- Canonical SMILES:
COC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)c1ccccc1-c1ccccc1
- InChi:
InChI=1S/C43H47N5O6S2/c1-46(2)27-24-34(31-55-36-14-8-5-9-15-36)44-40-23-22-37(30-41(40)48(50)51)56(52,53)45-42(49)33-18-20-35(21-19-33)47-28-25-43(54-3,26-29-47)39-17-11-10-16-38(39)32-12-6-4-7-13-32/h4-23,30,34,44H,24-29,31H2,1-3H3,(H,45,49)/t34-/m1/s1
- InChiKey:
DYEXZAMWDDJPBR-UUWRZZSWSA-N
External links
168315748 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 9.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 793.30 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 6.82 | |||
TPSA | 136.80 | |||
RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
17256834 | 8m | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 9.00 | |
17256834 | 8m | B2CL1 Q07817 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 9.30 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5402 | Navitoclax | DB12340 | |
0.4884 | Venetoclax | DB11581 | |
0.4455 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.4231 | 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid | DB02449 | |
0.4082 | Repinotan | DB06506 | |
0.4042 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.3968 | SC-74020 | DB01630 | |
0.3965 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.3902 | Zafirlukast | DB00549 | |
0.3893 | VX-659 | DB15177 | |
0.3846 | (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE | DB07583 | |
0.3846 | Pipotiazine | DB01621 | |
0.3826 | Omidenepag isopropyl | DB15071 | |
0.3822 | Sulfabenzamide | DB09355 | |
0.3821 | Anatibant | DB05038 |